Archive of Issues
Authors having problems with submissions please notify editor: editor@hvt-journal.com
Upcoming discussions, debates

On sweet undeniable feeling of power of international intellectual feudalism, bias, discrimination, censoring and theft

 

 

EDITORIALS

Requirements for research manuscripts submitted for consideration for publication in Heart Vessels and Transplantation

Full Text   |   PDF


EDITORIALS

From Editor-in-Chief

In this June 2019 issue of the journal you can find article on management of deep venous thrombosis in general surgery, review article on strategy of preservation subvalvular structures in mitral valve replacement surgery and quizzes on electrophysiology and pacemaker.

Full Text   |   PDF


EDITORIALS

Reviewers of the June 2019 issue

Full Text   |   PDF


EDITORIALS

From Editor-in-Chief

Full Text   |   PDF


EDITORIALS

On impact of articles published in Heart, Vessels and Transplantation and on responding to reviewers` comments

Full Text   |   PDF


EDITORIALS

From Editor-in-Chief: Peer-review experience at the Heart, Vessels and Transplantation

Full Text   |   PDF


EDITORIALS

The epidemiological situation of COVID-19 in the Kyrgyz Republic

The maximum number of cases of coronavirus infection was 79 (tested positive cases, including asymptomatic and cases with clinical manifestations) as of April 12, 2020. According to the forecast by the WHO methodology, the peak incidence of COVID-19 should be at the eighth week of the development of the epidemic process, amounting to 92 cases. Starting from the fifth week, the number of cases of COVID-19 tends to decrease gradually and the mathematical model for predicting the incidence of COVID-19 in the Kyrgyz Republic shows that by the end of May 2020, 97% of the total number of infected with coronavirus will be detected.

Full Text   |   PDF


EDITORIALS

COVID-19 and the cardiovascular system

The understanding of the pathophysiology of cardiovascular complications in COVID-19 is a key to the implementation of therapeutic measures, which may offer additional benefits, mainly for patients with severe disease, such as anticoagulants.

Full Text   |   PDF


EDITORIALS

From Editor-in-Chief: On Covid-19 pandemics and welcome to new editors

We would like to welcome our new editors: on cardiovascular diseases, pulmonary disease and pulmonary hypertension – Dr Baktybek Kojonazarov from Gessen, Germany; on cardiovascular surgery - Dr Jeffrey Shuhaiber from Boston MA, USA; on cardiology and high-altitude medicine - Prof. Akpay Sarybaev, Bishkek, Kyrgyzstan and on nuclear cardiology and cardiology - Dr Andrea Rocha de Lorenzo from Rio de Janeiro, Brazil. Our team of editors’ feels enriched with invaluable expertise of our new members.

Full Text   |   PDF


EDITORIALS

From Editor-in-Chief: Has everything changed during pandemic: peer-review, science, clinical practices and education, CV diseases?

Full Text   |   PDF


EDITORIALS

NT-pro-BNP in cardiac surgery

The use of the laboratory criterion NT-proBNP makes it possible to objectively diagnose myocardial dysfunction with high analytical sensitivity and specificity; nevertheless, it is always necessary to compare complaints and Echo-CG data with NT-proBNP data.

Full Text   |   PDF



EDITORIALS

What is new with AF guidelines 2020?

Full Text   |   PDF


EDITORIALS

From Editor-in-Chief: On current issue, guidelines and updates, pandemics, academic advancement, ethics, and diversity

In this issue March 2021 issue of the Heart, Vessels and Transplantation journal you may find editorial on what is new in 2020 atrial fibrillation (AF) guideline, research article on pericardial involvement after cardiac surgery and reviews on syncope evaluation and biomarkers in congenital heart disease, case reports on infectious endocarditis in acute coronary syndrome, Texidor`s twinge as a cause of chest pain, quizzes on electrocardiography and interventional cardiology, and interesting commentary on literature and medicine.

Full Text   |   PDF


EDITORIALS

From Editor-in-Chief: On current issue, important cardiovascular documents and trials, COVID-19 sequels, and welcome to the new Editors

Full Text   |   PDF


EDITORIALS

What is new in cardiac pacing ESC guidelines 2021?

New sections have appeared concerning patient workout before implantation, but also concerning the new modalities of conduction system pacing, and a new section on perioperative management. We summarize here the key points from these International guidelines.

Full Text   |   PDF


EDITORIALS

From Editor-in-Chief: On September 2021 issue, hot trials at ESC congress this year, and updates on pandemics

Full Text   |   PDF


EDITORIALS

New in the diagnosis of heart failure and management of associated conditions in 2021 ESC guidelines

Heart failure (HF) is a major health problem affecting millions of people worldwide. The report about heart disease and stroke statistics claimed that almost 6.0 million Americans ≥20 years of age had HF based on the results of 2015-2018 The National Health and Nutrition Examination Survey (NHANES) (1)

Full Text   |   PDF


EDITORIALS

Current pharmacological treatment of heart failure: What is new in the 2021 ESC guidelines?

The current guidelines are a breakthrough in the approach to heart failure not only because of new therapies, but mainly because of the approach to treatment. The newest recommendations mark the beginning of an era in which personalization of implemented therapies comes to the fore

Full Text   |   PDF


EDITORIALS

What is new in valvular heart disease ESC Guidelines 2021?

Full Text   |   PDF